Jerome Zisfein is a Cardiology physician. OpenAlex indexes 13 publications with 268 citations (h-index 9).
Overview
Scholarship
indexed output and impact (OpenAlex)Publications indexed by OpenAlex. Counts exclude supporting files.
Citations across these publications.
H-index from these publications.
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
Telephone
Practice address and telephone from the federal NPPES registry.
Sign in to view contact details →Industry payments
5 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- Boston Scientific CorporationProgram year20251 payment
- Novo Nordisk IncProgram year20253 payments
- Novartis Pharmaceuticals CorporationProgram year20252 payments
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Cardiovascular
84.5%Statin21.8%Atorvastatin Calcium54%Rosuvastatin Calcium37%Simvastatin9%Part D≥159 patientsBeta blocker18.9%Metoprolol Succinate68%Metoprolol Tartrate8%Labetalol Hcl7%Atenolol7%Carvedilol7%Sotalol2%Propranolol Hcl Er1%Part D<11 patients+ 15 more classes in this area
Blood & clotting
10.7%Factor Xa inhibitor7.1%Xarelto57%Eliquis43%Part D≥44 patientsP2Y12 inhibitor3.4%Clopidogrel88%Prasugrel Hcl12%Part D<11 patients+ 1 more class in this area
Metabolism & gastrointestinal
2.9%Proton pump inhibitor1.9%Pantoprazole Sodium68%Omeprazole32%Part D<11 patientsPotassium supplement0.4%Potassium Chloride100%Part D<11 patients+ 2 more classes in this area
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- No association of amyotrophic lateral sclerosis with cancer.
PubMed
1988 - Risks of lumbar puncture in the presence of intracranial mass lesions.
PubMed
1988 - A serum protease cleaves proANF into a 14-kilodalton peptide and ANF
American Journal of Physiology-Endocrinology and Metabolism
1987
Similar KOLs
Other experts from the same institution or the same specialty.
No other directory profiles share this institution yet.
Deepak Bhatt, MD
Icahn School of Medicine at Mount Sinai
Harlan Krumholz, MD
Yale School of Medicine
Martin Leon, MD
Columbia University Irving Medical Center
Scott Solomon, MD
Brigham and Women's Hospital
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments, shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet. Reviewed account links and congress post links can appear separately. Absence of a section means “not yet looked,” never “none found.”